spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

Outsourcing in Clinical Trials Nordics 2017

Outsourcing in Clinical Trials Nordics 2017

10-11 October 2017
Copenhagen, Denmark

Enabling local knowledge-sharing, benchmarking and network-building between Nordic biopharma and device industry peers

Outsourcing Clinical Trials Nordics was a great success again in 2016 and we are excited to announce that we will be returning to Copenhagen on 10th – 11th October 2017. The 2 day event last September saw over 150 delegates working on clinical trials from pharmaceutical, biotech and medical device companies come together to discuss the industry’s biggest operational and outsourcing challenges.

The streamed agenda allows delegates to tailor their day and during the networking sessions delegates are able to meet service providers and colleagues.

web www.arena-international.com/octnordics
email Copenhagen, Denmark
 
Print this page
Send to a friend
   
spacer
Industry Events

Outsourcing in Clinical Trials Nordics 2017

10-11 October 2017, Copenhagen, Denmark

Enabling local knowledge-sharing, benchmarking and network-building between Nordic biopharma and device industry peers
More info >>

White Papers

Orthogonal Approaches for the Analysis of Protein Sequence

Ludger Ltd

One of the most important classes of biopharmaceuticals is monoclonal antibodies. They are expressed from living cells, and are consequently subject to complex biochemical pathways. Not all of these routes are fully understood, and many are sensitive to the subtlest of environmental changes. Changes such as these can affect the final biopharmaceutical sequence, structure and post-translational modifications, not to mention any changes that may occur during further purification. This often means that the final product from one batch may be different from the last in another batch. Each batch is a complicated mix of similar molecules, and analysis of the degree of batch-to-batch variation is therefore very important to the establishment of the drug's safety for medicinal use and patient administration.
More info >>


News and Press Releases

CPhI India Report identifies two-tier manufacturing market and predicts increased acquisitions


More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement